Share:
Share this content in WeChat
X
Review
Current status of magnetization transfer imaging in psychiatric disorders
ZHANG Ti-jiang  GONG Qi-yong 

DOI:10.3969/j.issn.1674-8034.2010.06.015.


[Abstract] For many central nervous system diseases, MRI has been proved to be a sensitive tool for detecting abnormalities, understanding site and extent of lesions. Despite such a high sensitivity, conventional MRI does not provide an accurate assessment for subtle or early neuropathological changes in some disorders. Magnetization transfer imaging (MTI) is a relative new, more sensitive MRI technique to detect subtle pathological changes of macromolecular structure. MTI can selectively decrease macromolecular tissue signal through applying off-resonance saturating pulses, thus improving image contrast and acquiring more tissue structural information. Many studies have suggested that MTI can detect brain abnormalities of normal-appearing white and gray matter on conventional MRI, such as multiple sclerosis. Recently, there is growing evidence that MTI can provide new complementary information for better understanding pathophysiological mechanism of psychiatric disease. In this review, we summarized clinical application and advancement of MTI in psychiatric disorders.
[Keywords] Magnetization transfer imaging;Psychiatric disorders;Magnetic resonance imaging

ZHANG Ti-jiang Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China; Department of Radiology, Affiliated Hospital of Zunyi Medical College, Zunyi 563003, China

GONG Qi-yong* Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China

*Correspondence to: Gong QY, E-mail: qygong05@126.com

Conflicts of interest   None.

Received  2010-04-21
Accepted  2010-08-05
DOI: 10.3969/j.issn.1674-8034.2010.06.015
DOI:10.3969/j.issn.1674-8034.2010.06.015.

[1]
Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med, 1989, 10(1): 135-144.
[2]
Wolff SD, Balaban RS. Magnetization transfer imaging: practical aspects and clinical applications. Radiology, 1994, 192(3): 593-599.
[3]
Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. NMR Biomed, 2001, 14(2): 57-64.
[4]
Yuan Y, Lang ZJ, Han YC, et al. Magnetization transfer contrast time of flight magnetic resonance angiography. Chin J Radiol, 1997, 31(9): 642-644.
[5]
Lin Q, Shen MH, Luo SM, et al. The value of magnetzation trasfer contrast time of flight magnetic resonance angiography in the diagnosis brian tumor. Chin J Radiol, 1999, 33(12): 847-849.
[6]
Miao Y, Lin W, Qian YE, et al. Contrast enhanced magnetisation transfer MRI in small lung metastatic lesions of the brain.Chin J Radiol, 2004, 38(12): 1252-1255.
[7]
Filippi M, Rocca M. Magnetization Transfer Magnetic Resonance Imaging of the Brain, Spinal Cord, and Optic Nerve. Experimental NeuroTherapeutics, 2007, 4(3): 401-413.
[8]
Eng J, Ceckler TL, Balaban RS. Quantitative 1H magnetization transfer imaging in vivo. Magn Reson Med, 1991, 17(2): 304-314.
[9]
Balaban RS, Ceckler TL. Magnetization transfer contrast in magnetic resonance imaging. Magn Reson Q, 1992,8(2): 116-137.
[10]
Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post-mortem multiple sclerosis brain. Neuroimage, 2007, 35(2): 467-477.
[11]
Smith RC, Calderon M, Ravichandran GK, et al. Nuclear magnetic resonance in schizophrenia: a preliminary study. Psychiatry Res, 1984, 12(2): 137-147.
[12]
Shenton ME, Dickey CC, Frumin M, et al. A review of MRI findings in schizophrenia. Schizophr Res, 2001,49(1-2): 1-52.
[13]
Foong J, Maier M, Barker GJ. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry, 2000, 68(1): 70-74.
[14]
Foong J, Symms MR, Barker GJ, et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain, 2001, 124(5): 882-892.
[15]
Bagary MS, Symms MR, Barker GJ, et al. Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Arch Gen Psychiatry, 2003, 60(8): 779-788.
[16]
Bagary MS, Hutton SB, Symms MR, et al. Structural neural networks subserving oculomotor function in first-episode schizophrenia. Biol Psychiatry, 2004, 56(9): 620-627.
[17]
Price G, Cercignani M, Chu EM, et al. Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. NeuroImage, 2010, 49(1-24): 185-192.
[18]
Kubicki M, Park H, Westin CF, et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage, 2005, 26(4): 1109-1118.
[19]
Mandl RC, Schnack HG, Luigjes J, et al. Tract-based Analysis of Magnetization Transfer Ratio and Diffusion Tensor Imaging of the Frontal and Frontotemporal Connections in Schizophrenia. Schizophr Bull, 2010,36(4):778-787.
[20]
Kalusa P, Slotboomb J, Gallinata Ju. The amygdala in schizophrenia: a trimodal magnetic resonance imaging study. Neuroscience Letters, 2005, 375(3):151-156.
[21]
Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet, 2009, 373(9680): 2041-2053.
[22]
Aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. CMAJ, 2009, 180(3): 305-313.
[23]
Nauta WJ. Neural associations of the frontal cortex. Acta Neurobiol Exp (Wars), 1972, 32(2): 125-140.
[24]
Weniger G, Lange C, Irle E. Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder. J Affect Disord, 2006, 94(1): 219-229.
[25]
Monkul ES, Hatch JP, Nicoletti MA, et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry, 2007, 12(4): 360-366.
[26]
Wyckoff N, Kumar A, Gupta RC, et al. Magnetization transfer imaging and magnetic resonance spectroscopy of normal-appearing white matter in late-life major depression. J Magn Reson Imaging, 2003, 18(5): 537-543.
[27]
Kumar A, Gupta RC, Albert Thomas M, et al. Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer. Psychiatry Res, 2004, 130(2):131-140.
[28]
Kumar A, Gupta R, Thomas A, et al. Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression. Arch Gen Psychiatry, 2009,66(3): 324-330.
[29]
Gunning-Dixon FM, Hoptman MJ, Lim KO, et al. Macromolecular white matter abnormalities in geriatric depression: a magnetization transfer imaging study. Am J Geriatr Psychiatry, 2008, 16(4): 255-262.
[30]
Hoptman MJ, Gunning-Dixon FM, Murphy CF, et al. Structural neuroimaging research methods in geriatric depression. Am J Geriatr Psychiatry, 2006, 14(10): 812-822.
[31]
Zhang TJ, Wu QZ, Huang XQ, et al. Magnetization transfer imaging reveals the brain deficit in patients with treatment-refractory depression. J Affect Disord, 2009,117(3): 157-161.
[32]
Bruno SD, Barker GJ, Cercignani M, et al. A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry. Brain, 2004, 127(11): 2433-2440.
[33]
Bruno SD, Papadopoulou K, Cercignani M, et al. Structural brain correlates of IQ changes in bipolar disorder. Psychol Med, 2006, 36(5): 609-618.
[34]
Peterson BS, Thomas P, Kane MJ, et al. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry, 2003, 60(4): 415-424.
[35]
Moriarty J, Varma AR, Stevens J, et al. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology, 1997, 49(2): 410-415.
[36]
Garraux G, Goldfine A, Bohlhalter S, et al. Increased midbrain gray matter in Tourette's syndrome. Ann Neurol, 2006, 59(2): 381-385.
[37]
Müller-Vahl KR, Kaufmann J, Grosskreutz J, et al. Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci, 2009, 10: 47( DOI: 10.1186/147-2202-10-47).

PREV Improved diagnosis of breast diseases with Siemens MR techniques
NEXT Utilization of low-field MR scanner on cerebral diseases
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn